Parkman Healthcare Partners’s RxSight RXST Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $8.24M | Buy |
633,874
+2,636
| +0.4% | +$34.3K | 0.95% | 38 |
|
|
2025
Q1 | $15.9M | Buy |
631,238
+330,540
| +110% | +$8.35M | 1.89% | 18 |
|
|
2024
Q4 | $10.3M | Buy |
300,698
+116,378
| +63% | +$4M | 1.38% | 27 |
|
|
2024
Q3 | $9.11M | Sell |
184,320
-112,419
| -38% | -$5.56M | 1.16% | 31 |
|
|
2024
Q2 | $17.9M | Sell |
296,739
-115,693
| -28% | -$6.96M | 2.39% | 9 |
|
|
2024
Q1 | $21.3M | Sell |
412,432
-100,600
| -20% | -$5.19M | 2.61% | 9 |
|
|
2023
Q4 | $20.7M | Buy |
513,032
+131,701
| +35% | +$5.31M | 2.91% | 8 |
|
|
2023
Q3 | $10.6M | Sell |
381,331
-117,300
| -24% | -$3.27M | 1.95% | 11 |
|
|
2023
Q2 | $14.4M | Buy |
498,631
+70,838
| +17% | +$2.04M | 2.49% | 12 |
|
|
2023
Q1 | $7.14M | Buy |
427,793
+251,372
| +142% | +$4.19M | 1.55% | 27 |
|
|
2022
Q4 | $2.24M | Buy |
176,421
+9,660
| +6% | +$122K | 0.6% | 54 |
|
|
2022
Q3 | $2M | Buy |
166,761
+51,761
| +45% | +$621K | 0.57% | 55 |
|
|
2022
Q2 | $1.62M | Buy |
+115,000
| New | +$1.62M | 0.6% | 47 |
|